Fenbufen
Fenbufen is a nonsteroidal anti-inflammatory drug in the propionic acid derivatives class.[1]
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.048.148 |
Chemical and physical data | |
Formula | C16H14O3 |
Molar mass | 254.2854 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
It was introduced by American Cyanamid under the trade name Lederfen in the 1980s. Due to liver toxicity, it was withdrawn from markets in the developed world in 2010.[2][3]:370, 383–384
As of 2015 it was available in Taiwan and Thailand under several brand names.[4]
References
- Brogden RN (1986). "Non-steroidal anti-inflammatory analgesics other than salicylates". Drugs. 32 Suppl 4: 27–45. doi:10.2165/00003495-198600324-00004. PMID 3552584. S2CID 25471102.
- "Deleted products 2010". Monthly Index of Medical Specialities.
- Lewis JH, Stine JG (2013). "Nonsteroidal Antiinflammatory Drugs and Leukotriene Receptor Antagonists. Chapter 22". In Kaplowitz N, DeLeve LD (eds.). Drug-Induced Liver Disease (3rd ed.). Academic Press. ISBN 978-0-12-387818-2.
- "International listings for fenbufen". Drugs.com. Retrieved 25 June 2015.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.